It’s impossible to acknowledge the recent federal election result without also recognising the huge opportunity that comes with a new government, new leaders, and new members of our national parliament. A new government brings an injection of fresh perspectives on the hill in Canberra and a new opportunity to influence the key policies and directions nationally for cancer.
Content from the online Master of Cancer Sciences, jointly facilitated by the University of Melbourne and the VCCC Alliance, has beaten out the likes of Microsoft and Harvard Business School to claim gold in the international 2022 Telly Awards.
The VCCC Alliance has been awarded the ARCS 2022 Innovation Award (Organisation) for the SKILLED Clinical Trials Internship Program. The award acknowledges an organisation which showed creativity, resolve and resilience to solve what seemed like intractable issues in the face of the COVID-19 pandemic and beyond.
A series of five interactive educational webinars has been developed by Professor David Wiesenfeld, VCCC Alliance Research and Education Lead for Head and Neck Cancer, to address key questions in the management and treatment of tongue cancer under a multidisciplinary lens.
In 2018, the VCCC Alliance, supported by funding from the Victorian Government, led an innovative program to enable broader access to cancer clinical trials across regional areas, unimpeded by geographical location and local healthcare architecture. Four years down the track, this has been a game-changer.
Melbourne MicroCert scholarships have been awarded to an impressive cohort of cancer clinicians, researchers, clinical trial study coordinators, postdoctoral scientists and PhD students from VCCC Alliance member organisations and beyond.